|
|
Volumn 13, Issue 5, 2006, Pages 418-422
|
|
Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers
a
|
|
Author keywords
Adolescent; Extended release formulation of alprazolam; Pharmacokinetics; Xanax XR
|
|
Indexed keywords
4 HYDROXYALPRAZOLAM;
ALPHA HYDROXYALPRAZOLAM;
ALPRAZOLAM;
DRUG METABOLITE;
UNCLASSIFIED DRUG;
XANAX XR;
ADOLESCENT;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG FORMULATION;
DRUG MONITORING;
DRUG RELEASE;
DRUG SAFETY;
DRUG TOLERABILITY;
EXTENDED DRUG RELEASE;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
LABORATORY TEST;
LIQUID CHROMATOGRAPHY;
MALE;
MASS SPECTROMETRY;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
SOMNOLENCE;
VALIDATION PROCESS;
ADULT;
AGING;
ALPRAZOLAM;
ANTI-ANXIETY AGENTS;
AREA UNDER CURVE;
BIOTRANSFORMATION;
CHILD;
CROSS-OVER STUDIES;
DELAYED-ACTION PREPARATIONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
|
|
EID: 33748928813
PISSN: 10752765
EISSN: None
Source Type: Journal
DOI: 10.1097/01.mjt.0000182358.63457.48 Document Type: Article |
|
Times cited : (17)
|
|
References (6)
|
